outcomes from myeloma xi - what do the results tell us?
Published 4 years ago • 39 plays • Length 1:59Download video MP4
Download video MP3
Similar videos
-
1:20
myeloma x and xi trials: outcomes for multiple myeloma patients
-
3:56
real-world analysis of treatment patterns and outcomes in newly diagnosed myeloma
-
3:38
outcomes for patients with multiple myeloma who have had first-line monoclonal antibody exposure
-
0:59
defining the origins of multiple myeloma
-
2:06
the importance of proteomic analysis in myeloma and future outlooks
-
1:08
the impact of extramedullary multiple myeloma on outcomes with ide-cel
-
2:25
novel ai model for personalized risk stratification & treatment in newly diagnosed multiple myeloma
-
6:23
results of maintenance therapy in high-risk myeloma patients | ajay nooka, md, mph, facp | asco 2023
-
4:58
overview of the toxicities associated with bispecific agents in multiple myeloma
-
9:25
mgus diagnosis: a step-by-step approach
-
4:26
outcomes of ird in r/r multiple myeloma in routine clinical practice
-
2:37
the epigenomics of myeloma
-
1:25
predictors and outcomes of extramedullary disease in multiple myeloma
-
1:40
utilizing ai for individualized treatment-adjusted risk stratification in newly diagnosed myeloma
-
1:50
real-world outcomes of teclistamab treatment in r/r multiple myeloma
-
2:44
myeloma qol through induction and maintenance
-
2:46
managing patients with high-risk myeloma
-
4:00
optimizing the outcomes of autohsct in multiple myeloma
-
1:57
using molecular abnormalities for risk stratification in multiple myeloma at the time of diagnosis
-
2:33
an update on antibody-based treatment approaches in multiple myeloma
-
1:36
identification of high-risk disease using molecular profiling by mymap